ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
PsiOxus Achieves $15M BMS Milestone
contractpharma
December 13, 2017PsiOxus Therapeutics’?Clinical Trial Application for NG-348, an “armed” oncolytic virus for the treatment of solid tumors, has been approved, triggering a $15 million milestone payment from development partner,?Bristol-Myers Squibb.
Pharma Sources Insight July 2025
